Dentanol Reviews: Chewable Oral Probiotic Tablet Delivering 5.6 Billion CFU Enters the U.S. Dental Supplement Market

Dentanol announces U.S. availability of a once-daily chewable tablet pairing three probiotic strains with inulin, peppermint and pine gum resin. 5.6 billion CFU per serving. Dentanol is a chewable oral probiotic tablet supplying 5.6 billion colony-forming units per serving from three bacterial strains, combined with a prebiotic fiber, a botanical leaf extract and a tree resin powder. It is taken as one tablet daily with an 8 oz. glass of water and is available in one-, three- and six-bottle configurations through BuyGoods.

AURORA, Colorado, August 14, 2026 — Approximately 46 percent of U.S. adults aged 30 and older had periodontitis in 2009 to 2012, representing roughly 64.7 million people, with 8.9 percent classified as having severe periodontitis, according to national surveillance estimates published by researchers at the Centers for Disease Control and Prevention (Eke, P.I., et al., 2015, “Update on prevalence of periodontitis in adults in the United States: NHANES 2009–2012,” Journal of Periodontology, 86(5):611–622; PMID 25688694).

The scale of that figure has shifted consumer attention toward preventive oral care products that act on the bacterial composition of the mouth rather than on mechanical plaque removal alone. Into that category, Dentanol has announced U.S. commercial availability of its chewable oral probiotic tablet, a six-ingredient formula built around three probiotic strains and three supporting ingredients drawn from prebiotic, botanical and resin research.

→ Product information, the full supplement facts panel and current package options are published at globenewstoday.com/recommends/dentanol/.

Product Overview

This release reports the commercial availability of Dentanol in the U.S. oral care supplement market. Dentanol is a chewable dietary supplement combining two ingredient layers: a probiotic layer of three bacterial strains, and a supporting layer of three non-bacterial ingredients — inulin from chicory root, peppermint leaf extract powder and pine gum resin powder.

The delivery format is a point of difference worth stating plainly. Conventional probiotic capsules are swallowed whole and dissolve in the stomach or intestine. Dentanol is formulated as a chewable tablet, which exposes its contents to the oral cavity before they are swallowed. That design is consistent with an oral-cavity target rather than a purely gastrointestinal one, though the label does not state a mechanism and no study of the finished tablet is cited here.

One characteristic of the panel materially affects what a buyer can evaluate, and it is set out here rather than left for a reader to notice. The six active ingredients are declared as a single proprietary blend weighing 155 mg, with a combined potency of 5.6 billion CFU. Under 21 CFR 101.36, U.S. manufacturers may group ingredients this way and declare only the total weight of the blend. The practice is legal and widespread. Its consequence is that the amount of any individual ingredient in Dentanol — how much inulin, how much peppermint, how the 5.6 billion CFU divides between the three strains — is not disclosed and cannot be determined from the label. This release therefore reports what research exists on each ingredient without asserting that Dentanol contains a researched amount of any of them.

The bottle contains 30 chewable tablets, a one-month supply at the labeled serving of one tablet daily. Other ingredients are microcrystalline cellulose, xylitol DC, tricalcium phosphate, sucralose and magnesium stearate. Two of those warrant a note. Tricalcium phosphate supplies calcium and phosphate, the mineral ions that make up the bulk of tooth enamel, and xylitol is a sugar alcohol with its own oral-health research literature; both are listed as other ingredients rather than as part of the active blend. Sucralose is a non-nutritive sweetener of synthetic origin. Buyers who read the front-panel phrase “no artificial additives” as excluding synthetic sweeteners should read the other-ingredients line before purchase.

The front panel carries three structure-function statements — that the product nurtures a healthy oral microbiome and strong gums, supports naturally brighter and cleaner teeth, and supports fresh breath — each marked with the FDA disclaimer footnote reproduced at the end of this release.

Statement from the Company

“Dentanol was built on a simple premise: the mouth is a microbial environment, and most oral care products are designed to reduce bacteria rather than to support the balance of the community that lives there. We selected strains and supporting ingredients that have each been examined independently in the published literature. We want to be precise about what that does and does not mean. It means every ingredient in this formula has a research trail. It does not mean the finished product has been shown to reproduce the results of those studies, and we make no such claim. Dentanol is an addition to brushing, flossing and regular dental care, not a replacement for any of them.”

— Dentanol Product Development Team, Natures Formulas

Ingredient Research

The following section describes the six ingredients in the Dentanol proprietary blend as stated on the supplement facts panel, each accompanied by independently published research examining that ingredient.

Important qualification: all citations below describe research conducted under conditions unaffiliated with Dentanol. Several used specific strain designations, doses or delivery vehicles that differ from those used in this product, and because the blend is proprietary, the amount of each ingredient in Dentanol is not disclosed and cannot be compared against the amounts used in the research. These citations establish that each ingredient has been studied. They do not constitute clinical evidence that Dentanol produces equivalent outcomes, and no such equivalence is claimed.

Inulin (from chicory, Cichorium intybus root extract). A non-digestible fructan fiber included in the prebiotic role, meaning it is intended as a substrate for bacteria rather than as a bacterium itself. A systematic review published in Advances in Nutrition (Hughes, R.L., et al., 2022, “The prebiotic potential of inulin-type fructans: a systematic review,” doi:10.1093/advances/nmab119) synthesized human clinical trials in healthy adults and examined the effect of inulin-type fructans on the abundance of Bifidobacterium and Lactobacillus populations, alongside barrier function, mineral absorption and satiety endpoints. Trials in that literature have generally used inulin at gram-level daily intakes. The entire Dentanol blend weighs 155 mg, so the inulin content is necessarily a fraction of that figure and well below the intakes used in the cited research.

Lactobacillus paracasei. A lactic acid bacterium included for its studied relationship with oral microbial composition. A randomized, placebo-controlled trial published in Clinical Oral Investigations (Teanpaisan, R., et al., 2014, “Lactobacillus paracasei SD1, a novel probiotic, reduces mutans streptococci in human volunteers: a randomized placebo-controlled trial,” 18(3):857–862, doi:10.1007/s00784-013-1057-5) examined a specific L. paracasei isolate in 40 healthy adults over four weeks, measuring salivary mutans streptococci, lactobacilli and yeast counts. That trial used the designated SD1 strain; the Dentanol label identifies the species without a strain designation, so the ingredient cannot be matched to this or any other strain in the published literature.

Lactobacillus reuteri. One of the more extensively studied strains in periodontal research. A randomized, double-blind, placebo-controlled trial published in the Swedish Dental Journal (Krasse, P., et al., 2006, “Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri,” 30(2):55–60; PMID 16878680) enrolled 59 patients with moderate to severe gingivitis and evaluated two L. reuteri formulations against placebo over two weeks. Gingival index fell significantly in all three groups including placebo; one of the two formulations improved beyond placebo while the other did not, a within-study divergence that illustrates how much outcome depends on the particular preparation used. A later randomized placebo-controlled study in the Journal of Clinical Periodontology (Teughels, W., et al., 2013, “Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis,” 40(11):1025–1035, doi:10.1111/jcpe.12155) examined L. reuteri lozenges as an adjunct to scaling and root planing over 12 weeks. As above, no strain designation appears on the Dentanol label.

Bifidobacterium lactis BL-04. The one ingredient in this formula carrying a specific strain designation, which makes it the only one that can be matched to a named strain in the literature. A randomized, double-blind, placebo-controlled trial published in Clinical Nutrition (West, N.P., et al., 2014, “Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals,” doi:10.1016/j.clnu.2013.10.002) assigned 465 healthy active adults to BL-04, a second probiotic combination, or placebo, and measured the risk of upper respiratory illness episodes. Readers should note that this trial examined respiratory rather than oral endpoints; it is cited because it is the substantive human research on this strain, not because it bears on dental outcomes.

Peppermint (Mentha haplocalyx Briq.) leaf extract powder. A botanical used widely in oral care preparations, included for flavor and for its studied properties in the oral environment. A review published in the European Journal of Oral Sciences (Dobler, D., et al., 2020, “Effect of essential oils on oral halitosis treatment: a review,” doi:10.1111/eos.12745) examined essential oils used in halitosis management, including peppermint, and discussed menthol’s role in the bioactivity of mint oils as well as the observation that peppermint oil can increase salivation. That literature concerns peppermint essential oil; the Dentanol label specifies a leaf extract powder, which is a different preparation.

Pine (Pinus massoniana) gum resin powder. The least conventional ingredient in the formula and the one where the distinction between preparations matters most. Published research on Pinus species in oral and inflammatory contexts concerns bark extract, not gum resin. A randomized, double-blind, placebo-controlled trial published in Nutrients (2025, doi:10.3390/nu17091451) gave 91 periodontal aftercare patients French maritime pine bark extract at 100 mg twice daily or placebo following professional mechanical plaque removal, and reported reductions in salivary inflammatory biomarkers. A separate randomized placebo-controlled trial in Antioxidants (Ferguson, J.J.A., et al., 2022, “Antioxidant effects of a polyphenol-rich dietary supplement incorporating Pinus massoniana bark extract in healthy older adults,” doi:10.3390/antiox11081560) used 1,322 mg of Pinus massoniana bark extract daily for 12 weeks and reported reduced plasma malondialdehyde. Both studies used bark extract at doses far exceeding the entire 155 mg Dentanol blend. Gum resin is a different plant material with a different constituent profile, and the bark research should not be read as evidence for it.

What the Evidence Base Does and Does Not Show

The citations above are reported with their limitations attached rather than summarized favorably, because the limitations are what a buyer needs in order to judge them.

Three patterns run through the set. First, strain identity governs probiotic outcomes, and only one of the three strains in Dentanol carries a designation — the L. reuteri trial cited above found one formulation beat placebo while a second did not, within the same study. Second, preparation governs botanical outcomes: the peppermint literature concerns essential oil rather than leaf extract powder, and the pine literature concerns bark extract rather than gum resin. Third, and running through all of it, the proprietary blend means no ingredient amount is disclosed, so no dose comparison against any cited study is possible in either direction.

Ingredient research is a reason to examine a formula. It is not a substitute for testing the formula itself, and no published clinical trial has evaluated Dentanol as sold.

Format and Daily Use

Dentanol is positioned as an addition to an oral hygiene routine, not a replacement for one. The manufacturer’s stated support areas are oral microbiome balance, gum strength, tooth appearance and breath freshness. Individual experience varies with oral hygiene practices, diet, medication use and general health.

Brushing twice daily, cleaning between teeth, routine dental examinations and a balanced diet remain the established foundation of oral health. Anyone with persistent tooth pain, swollen or bleeding gums, loose teeth or other ongoing dental symptoms should seek evaluation from a licensed dental professional rather than relying on a dietary supplement.

Market Context

The figures below, from Market.us and Future Market Insights, are third-party industry context for the category, not claims by Dentanol about its own commercial performance.

The global oral health probiotics market was valued at approximately $107.0 million in 2025 and is projected to reach $329.3 million by 2035, at a compound annual growth rate of 11.9 percent, according to Market.us (Oral Health Probiotics Market Size and Share Report, Market.us, 2026; market.us). That assessment reported North America holding more than 41.3 percent of the market in 2025, or roughly $44.1 million in revenue, and capsules and tablets leading the format segment at 45.7 percent.

That figure describes the narrow segment in which Dentanol competes: probiotic supplements sold specifically for oral health. It sits inside a larger parent category that counts probiotics incorporated across toothpaste, mouthwash, chewing gum and other oral care formats, assessed at approximately $3.0 billion in 2025 and projected to reach $5.7 billion by 2035 at a compound annual growth rate of 6.5 percent, according to Future Market Insights (Probiotics for Oral Health Market Report, Future Market Insights, 2025; futuremarketinsights.com). The two figures are not competing estimates of the same thing; the smaller is a subset of the larger, and the gap between them reflects how much of the category sits in conventional oral care products rather than in supplements.

Availability and Pricing

Dentanol is sold through the manufacturer’s authorized retail portal, with order processing handled by BuyGoods. Three package configurations are listed at the time of this release:

One bottle (30-day supply) at $69, plus $9.99 shipping

Three bottles (90-day supply) at $59 per bottle, $177 total, with free U.S. shipping

Six bottles (180-day supply) at $49 per bottle, $294 total, with free U.S. shipping

All purchases are a one-time charge with no subscription or auto-ship enrollment applied by default. Pricing and promotional terms are set by the seller and subject to change; buyers should confirm current terms at checkout rather than relying on any third-party description, including this one.

→ Current package options, pricing and guarantee terms are listed at globenewstoday.com/recommends/dentanol/.

Every order is covered by a 60-day money-back guarantee administered by the seller, and buyers should retain their order confirmation and return instructions. The guarantee should not be assumed on orders placed through another channel unless the seller confirms it in writing.

Quality and Manufacturing

The label states that Dentanol is made in the USA with globally sourced ingredients and that the product has been manufactured in an FDA-registered facility. Under 21 CFR Part 111, dietary supplement manufacturers are required to comply with current Good Manufacturing Practice regulations covering production standards, ingredient identity testing, quality control and accurate labeling. FDA registration of a facility is a filing requirement and is not an FDA endorsement, approval or evaluation of any product made there.

The label does not name the manufacturing facility, and no certificate of analysis or third-party testing record was published on the pages reviewed for this release. Buyers wanting that documentation should request it from the distributor. The label carries a revision code of REV 08/25, and the CFU count is declared at time of manufacture rather than through the end of shelf life — a standard industry convention that buyers of any live-culture product should understand, since viable counts decline over time and with heat exposure.

Transactions are processed through BuyGoods (BuyGoods Inc., a Delaware corporation), a registered e-commerce retailer whose role does not constitute an endorsement, approval or review of the product or of any claim made in its promotion.

Usage Guidance and Safety Information

Dentanol is intended for adult use. The label directs users to take one chewable tablet daily with an 8 oz. glass of water, not to exceed the recommended dose, to store the product away from heat, light and humidity, and not to use it if the safety seal is damaged or missing. It states that the product is not for children under the age of 18, and that pregnant or nursing mothers and individuals with a known medical condition should consult a physician before use.

Live probiotic supplements warrant particular caution for people who are immunocompromised, have a central venous catheter, or have a condition affecting gut barrier integrity. These individuals should speak with a physician before starting any probiotic product.

The formula contains xylitol. Xylitol is well tolerated by people at the amounts typical of a single chewable tablet, but it is toxic to dogs even in small quantities, and households with pets should store the product accordingly. Individuals with a known sensitivity to sugar alcohols or to sucralose should review the other-ingredients line before use.

Individual results vary. This product is not a substitute for professional dental care and is not a treatment for any dental or medical condition.

Scope of This Announcement

This is a product availability announcement, not a clinical trial report, an efficacy claim or an independent product evaluation. No peer-reviewed trial of the finished Dentanol formula is cited, because the research referenced here concerns individual ingredients rather than the assembled product.

Three points bear on any evaluation. The active ingredients are declared as a proprietary blend, so no individual amount is disclosed and no dose comparison against the cited research is possible. Strain identity matters in probiotic science, and only one of the three strains here carries a designation. And the refund guarantee applies to the authorized retail portal; third-party listings may not carry the same terms.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Affiliate Disclosure: This press release contains a link to a retail partner website through which the distributor may receive compensation if a purchase is made following a referral, disclosed in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The affiliate relationship does not influence the factual content of this release. No compensation was provided to any researcher, journal or institution cited above, and no citation should be read as an endorsement of this product by its authors or publisher. This release is informational, is based on the product label combined with published research on the individual ingredients, and does not constitute medical or dental advice, diagnosis or treatment. Readers with active dental disease, gum disease or other oral health concerns should seek evaluation from a licensed dentist or periodontist.

About Dentanol

Dentanol is a chewable oral probiotic dietary supplement supplying 5.6 billion CFU per serving from Lactobacillus paracasei, Lactobacillus reuteri and Bifidobacterium lactis BL-04, combined with inulin from chicory root, peppermint leaf extract powder and pine gum resin powder. The product is made in the USA with globally sourced ingredients, manufactured in an FDA-registered facility, and distributed by Natures Formulas of Aurora, Colorado, through BuyGoods with a 60-day money-back guarantee. Dentanol is a dietary supplement and is not intended to diagnose, treat, cure or prevent any disease.

Media Contact

Kevin Shaw, Product Head at Dentanol

Dentanol Product Support

Email: Support@mydentanol.com

Phone: +1-877-766-1434

Website: https://mydentanol.com

Address: 19655 E 35th Dr #100, Aurora, CO 80011, USA

For more press release distribution and guest post services, visit TS Newswire.